With the analysis among 59 patents, we discovered top 22 key players by total patent application. AbbVie Biotherapeutics, Inc., IBC Pharmaceuticals, Inc., Shanghai Biomabs Pharmaceutical Co., Ltd. are dominant in this area. They take 37.29% of the total patent filing.
AbbVie Biotherapeutics, Inc.
Illinois, United States
Patent: 12
IBC Pharmaceuticals, Inc.
New Jersey, United States
Patent: 6
Shanghai Biomabs Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 3
AbMax Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 3
California, United States
Patent: 2
Hovedstaden, Denmark
Patent: 2
Lundbeck Seattle BioPharmaceuticals, Inc.
Washington, United States
Patent: 2
No data, please try another search term
With the analysis among related 7 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Amgen, Inc., Cell Therapy And Technology, S.a. De C.v., Tillotts Pharma AG take 42.86% of patent filing during this period.
California, United States
Patent: 1
Cell Therapy And Technology, S.a. De C.v.
undefined undefined
Patent: 1
Aargau, Switzerland
Patent: 1
Nanjing Legend Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
IBC Pharmaceuticals, Inc.
New Jersey, United States
Patent: 1
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among related 7 patents in last 5 years, we discover 3 new entrants.
Aargau, Switzerland
Patent: 1
Nanjing Legend Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Bio-Thera Solutions, Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among 12 patents, we discovered top 5 universities and scientific research institutions by total patent application. Carnegie Mellon University, Osaka University, National Cheng Kung University are dominant in this area. They take 58.33% of the total patent filing.
Carnegie Mellon University
Pennsylvania, United States
Patent: 3
National Cheng Kung University
Taiwan Province, China
Patent: 1
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 1